A robust protocol integrating cognitive, physiological, and omics data to assess individual and group responses to performance-enhancing interventions using machine learning and mathematical modeling. Validated in multiple studies, offering high sensitivity and specificity.
This innovative protocol offers a comprehensive method for evaluating performance- and tolerance-enhancing interventions by integrating cognitive, physiological, physical, biochemical, and translational -omics data. The approach uses machine learning and mathematical modeling to assess individual and group responses, providing a nuanced understanding of biological mechanisms. Successfully applied in DoD and DARPA-funded studies, this method has proven its ability to detect subtle yet impactful effects of interventions like nutrition, exercise training, and stress protocols.
This protocol is at Technology Readiness Level 7, indicating that it has been demonstrated in relevant environments and is ready for operational use in diverse settings.
UConn is a comprehensive public research university and the state’s flagship, with its main campus in Storrs and an academic medical center in Farmington. Industry engages through UConn Tech Park—anchored by the Innovation Partnership Building—with shared labs, pilot‑scale testbeds, and advanced prototyping for collaborators. Integration with UConn Health enables clinical collaborations and translation, while Hartford and Stamford campuses connect companies to talent along the New York–Boston corridor; a statewide extension network supports technology adoption. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, and DOD. A dedicated technology commercialization office and the Technology Incubation Program support IP, licensing, and startup incubation across multiple sites.